0000950170-24-116339.txt : 20241022 0000950170-24-116339.hdr.sgml : 20241022 20241022170917 ACCESSION NUMBER: 0000950170-24-116339 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241018 FILED AS OF DATE: 20241022 DATE AS OF CHANGE: 20241022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smeal Benjamin C. CENTRAL INDEX KEY: 0001748561 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36075 FILM NUMBER: 241387006 MAIL ADDRESS: STREET 1: 2221 OLYMPIC BLVD. CITY: WALNUT CREEK STATE: CA ZIP: 94561 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evoke Pharma Inc CENTRAL INDEX KEY: 0001403708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 208447886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: 858-345-1494 MAIL ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 4 1 ownership.xml 4 X0508 4 2024-10-18 0001403708 Evoke Pharma Inc EVOK 0001748561 Smeal Benjamin C. C/O EVOKE PHARMA, INC. 420 STEVENS AVENUE, SUITE 230 SOLANA BEACH CA 92075 true false false false false Stock Option (Right to Buy) 5.51 2024-10-18 4 A false 5833 0 A 2034-10-17 Common Stock 5833 5833 D 1/3rd of the total number of shares of common stock subject to the option shall vest following each one-year period after October 18, 2024, the date of grant, subject to the Reporting Person's continuous service to the Issuer through each vesting date, so that the option shall be fully vested on the third anniversary of the date of grant. /s/ Matthew J. D'Onofrio, Attorney-in-fact for Benjamin C. Smeal 2024-10-22